Related Experiment Video
Updated: Jul 7, 2026

Studying Wnt Signaling During Patterning of Conducting Airways
Published on: October 16, 2016
Ectopic SOX9 mediates extracellular matrix deposition characteristic of organ fibrosis
Karen Piper Hanley1, Fiona Oakley, Sarah Sugden
1Centre for Human Development, Stem Cells & Regeneration. k.piper@soton.ac.uk
Abstract:
Appropriate temporospatial expression of the transcription factor SOX9 is important for normal development of a wide range of organs. Here, we show that when SOX9 is expressed ectopically, target genes become expressed that are associated with disease. Histone deacetylase inhibitors in clinical trials for cancer therapy induced SOX9 expression via enhanced recruitment of nuclear factor Y (NF-Y) to CCAAT elements in the SOX9 proximal promoter. The effect of histone deacetylase inhibitors could be elicited in cells that normally lack SOX9, such as hepatocytes. In human fetal hepatocytes, this aberrant induction of SOX9 protein caused ectopic expression of COL2A1 and COMP1 that encode extracellular matrix (ECM) components normally associated with chondrogenesis. Previously, ectopic expression of this "chondrogenic" profile has been implicated in vascular calcification. More broadly, inappropriate ECM deposition is a hallmark of fibrosis. We demonstrated that induction of SOX9 expression also occurred during activation of fibrogenic cells from the adult liver when the transcription factor was responsible for expression of the major component of fibrotic ECM, type 1 collagen. These combined data identify new aspects in the regulation of SOX9 expression. They support a role for SOX9 beyond normal development as a transcriptional regulator in the pathology of fibrosis.
Insights
Ectopic SOX9 expression, induced by histone deacetylase inhibitors, drives disease-associated gene expression. This SOX9 role in fibrosis suggests new therapeutic targets for liver disease.
Area of Science:
- Developmental Biology
- Molecular Biology
- Pathology
Background:
- SOX9 is crucial for organ development.
- Aberrant SOX9 expression is linked to disease.
- Histone deacetylase inhibitors (HDACi) are used in cancer therapy.
Purpose of the Study:
- Investigate SOX9 regulation by HDACi.
- Determine SOX9's role in disease pathology, specifically fibrosis.
Main Methods:
- Utilized histone deacetylase inhibitors to induce SOX9 expression.
- Examined SOX9's effect on gene expression in hepatocytes and fibrogenic cells.
- Analyzed SOX9's role in extracellular matrix (ECM) deposition.
Main Results:
- HDACi induced SOX9 expression in cells lacking it, like hepatocytes.
- Ectopic SOX9 triggered chondrogenic gene expression (COL2A1, COMP1) in fetal hepatocytes.
- SOX9 drove type 1 collagen expression in activated adult liver fibrogenic cells, a key fibrotic ECM component.
Conclusions:
- SOX9 expression is regulated by enhanced nuclear factor Y (NF-Y) recruitment to the SOX9 promoter by HDACi.
- SOX9 contributes to fibrosis by regulating ECM deposition.
- SOX9 has a role in disease pathology beyond normal development.
More Related Videos
Related Concept Videos
Pleiotropy
Extracellular Matrix
The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
The Extracellular Matrix
Role of Matrix Metalloproteases in Degradation of ECM
A...
Cell-matrix's Response to Mechanical Forces
Anchoring junctions mechanically attach a cell to the...

